Nifty
Sensex
:
:
10799.65
36674.52
36.00 (0.33%)
187.24 (0.51%)

Pharmaceuticals & Drugs - Global

Rating :
80/99

BSE: 500420 | NSE: TORNTPHARM

2333.15
07-Jul-2020
  • Open
  • High
  • Low
  • Previous Close
  •  2346.00
  •  2374.00
  •  2304.40
  •  2347.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  588076
  •  13780.32
  •  2699.00
  •  1452.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 39,739.51
  • 38.77
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 44,961.57
  • 0.72%
  • 8.24

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 71.25%
  • 1.28%
  • 6.43%
  • FII
  • DII
  • Others
  • 9.82%
  • 10.16%
  • 1.06%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.71
  • 3.49
  • 10.09

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.79
  • -4.48
  • 9.97

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.26
  • -9.98
  • 14.75

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.81
  • 28.47
  • 41.98

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.89
  • 6.13
  • 5.85

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.55
  • 15.00
  • 17.13

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Net Sales
1,946.00
1,856.00
4.85%
1,966.00
2,051.00
-4.14%
2,005.00
1,894.00
5.86%
2,022.00
1,872.00
8.01%
Expenses
1,398.00
1,383.00
1.08%
1,426.00
1,490.00
-4.30%
1,464.00
1,421.00
3.03%
1,481.00
1,395.00
6.16%
EBITDA
548.00
473.00
15.86%
540.00
561.00
-3.74%
541.00
473.00
14.38%
541.00
477.00
13.42%
EBIDTM
28.16%
25.48%
27.47%
27.35%
26.98%
24.97%
26.76%
25.48%
Other Income
15.00
17.00
-11.76%
53.00
3.00
1,666.67%
34.00
10.00
240.00%
20.00
27.00
-25.93%
Interest
102.00
123.00
-17.07%
111.00
133.00
-16.54%
116.00
126.00
-7.94%
122.00
122.00
0.00%
Depreciation
168.00
160.00
5.00%
163.00
156.00
4.49%
163.00
152.00
7.24%
160.00
150.00
6.67%
PBT
293.00
-150.00
-
319.00
275.00
16.00%
296.00
205.00
44.39%
279.00
232.00
20.26%
Tax
-21.00
2.00
-
68.00
29.00
134.48%
52.00
26.00
100.00%
63.00
69.00
-8.70%
PAT
314.00
-152.00
-
251.00
246.00
2.03%
244.00
179.00
36.31%
216.00
163.00
32.52%
PATM
16.14%
-8.19%
12.77%
11.99%
12.17%
9.45%
10.68%
8.71%
EPS
18.56
-8.98
-
14.83
14.54
1.99%
14.42
10.58
36.29%
12.77
9.63
32.61%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
-
7,939.31
7,672.80
5,949.83
5,815.69
6,686.93
4,653.45
4,184.72
3,211.14
2,695.92
2,197.79
Net Sales Growth
-
3.47%
28.96%
2.31%
-13.03%
43.70%
11.20%
30.32%
19.11%
22.67%
 
Cost Of Goods Sold
-
1,981.79
2,041.26
1,535.17
1,629.66
1,452.21
1,280.96
1,107.58
807.98
774.38
616.64
Gross Profit
-
5,957.52
5,631.54
4,414.66
4,186.03
5,234.72
3,372.49
3,077.14
2,403.16
1,921.54
1,581.16
GP Margin
-
75.04%
73.40%
74.20%
71.98%
78.28%
72.47%
73.53%
74.84%
71.28%
71.94%
Total Expenditure
-
5,768.95
5,689.74
4,600.58
4,438.42
3,957.13
3,633.29
3,233.24
2,518.92
2,203.54
1,810.01
Power & Fuel Cost
-
128.19
132.46
118.77
107.98
92.59
97.41
71.88
62.80
56.97
42.53
% Of Sales
-
1.61%
1.73%
2.00%
1.86%
1.38%
2.09%
1.72%
1.96%
2.11%
1.94%
Employee Cost
-
1,429.04
1,403.79
1,135.25
993.41
842.35
841.81
741.10
623.29
531.80
440.44
% Of Sales
-
18.00%
18.30%
19.08%
17.08%
12.60%
18.09%
17.71%
19.41%
19.73%
20.04%
Manufacturing Exp.
-
544.11
511.16
457.58
502.16
353.45
345.98
320.78
278.15
225.27
210.89
% Of Sales
-
6.85%
6.66%
7.69%
8.63%
5.29%
7.43%
7.67%
8.66%
8.36%
9.60%
General & Admin Exp.
-
801.98
811.58
677.71
578.05
637.92
477.59
399.07
324.55
255.89
206.88
% Of Sales
-
10.10%
10.58%
11.39%
9.94%
9.54%
10.26%
9.54%
10.11%
9.49%
9.41%
Selling & Distn. Exp.
-
807.39
738.03
641.30
567.70
547.05
574.40
461.53
393.07
322.29
274.61
% Of Sales
-
10.17%
9.62%
10.78%
9.76%
8.18%
12.34%
11.03%
12.24%
11.95%
12.49%
Miscellaneous Exp.
-
76.45
51.46
34.80
59.46
31.56
15.14
131.30
29.08
36.94
274.61
% Of Sales
-
0.96%
0.67%
0.58%
1.02%
0.47%
0.33%
3.14%
0.91%
1.37%
0.82%
EBITDA
-
2,170.36
1,983.06
1,349.25
1,377.27
2,729.80
1,020.16
951.48
692.22
492.38
387.78
EBITDA Margin
-
27.34%
25.85%
22.68%
23.68%
40.82%
21.92%
22.74%
21.56%
18.26%
17.64%
Other Income
-
121.30
57.05
298.84
223.30
228.80
285.55
38.13
43.36
52.78
56.23
Interest
-
450.71
503.75
308.48
205.56
183.98
175.16
58.63
33.80
39.45
39.13
Depreciation
-
654.38
617.69
408.60
306.92
237.55
190.74
87.00
82.69
81.73
62.56
PBT
-
1,186.57
918.67
931.01
1,088.09
2,537.07
939.81
843.98
619.09
423.98
342.33
Tax
-
161.85
125.35
252.87
154.51
610.17
188.84
180.07
146.69
72.32
72.17
Tax Rate
-
13.64%
22.32%
27.16%
14.20%
26.04%
20.09%
21.34%
25.22%
20.17%
21.08%
PAT
-
1,024.72
436.28
678.11
933.55
1,733.24
750.94
663.88
432.76
284.04
270.17
PAT before Minority Interest
-
1,024.72
436.31
678.14
933.58
1,733.27
750.97
663.91
434.91
286.30
270.17
Minority Interest
-
0.00
-0.03
-0.03
-0.03
-0.03
-0.03
-0.03
-2.15
-2.26
0.00
PAT Margin
-
12.91%
5.69%
11.40%
16.05%
25.92%
16.14%
15.86%
13.48%
10.54%
12.29%
PAT Growth
-
134.88%
-35.66%
-27.36%
-46.14%
130.81%
13.11%
53.41%
52.36%
5.13%
 
EPS
-
60.56
25.78
40.08
55.17
102.44
44.38
39.24
25.58
16.79
15.97

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
4,823.22
4,724.35
4,622.19
4,350.13
3,494.10
2,490.56
1,902.43
1,421.93
1,193.83
1,022.40
Share Capital
84.62
84.62
84.62
84.62
84.62
84.62
84.62
42.31
42.31
42.31
Total Reserves
4,738.60
4,639.73
4,537.57
4,265.51
3,409.48
2,405.94
1,817.81
1,379.62
1,151.52
980.10
Non-Current Liabilities
3,299.15
3,861.40
4,142.42
2,303.33
1,994.65
2,504.92
926.76
619.81
487.73
397.60
Secured Loans
3,302.29
3,909.81
4,105.31
2,229.57
1,839.46
2,171.60
730.72
403.19
223.83
170.59
Unsecured Loans
1.56
3.11
6.15
11.26
10.62
13.62
13.74
51.35
98.22
122.45
Long Term Provisions
338.34
288.52
286.66
263.04
246.36
207.49
190.43
129.51
110.45
56.14
Current Liabilities
5,482.21
5,165.32
5,202.17
2,738.26
3,285.48
2,823.75
2,174.58
1,710.65
1,362.84
1,114.09
Trade Payables
2,076.86
2,096.74
2,048.24
1,749.32
2,260.22
1,827.72
1,429.13
1,067.74
863.47
615.00
Other Current Liabilities
1,860.80
1,641.26
1,151.68
687.14
822.28
446.15
371.63
275.83
291.00
312.85
Short Term Borrowings
1,090.85
934.11
1,625.60
0.00
3.32
319.07
210.43
124.62
138.12
99.57
Short Term Provisions
453.70
493.21
376.65
301.80
199.66
230.81
163.39
242.46
70.25
86.66
Total Liabilities
13,604.58
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
3,047.90
2,535.69
Net Block
7,533.12
7,747.71
7,854.68
3,688.44
2,859.08
2,832.66
875.34
819.82
796.87
635.55
Gross Block
10,334.13
9,935.43
9,449.48
4,909.80
3,793.53
3,542.93
1,420.04
1,278.15
1,199.64
964.28
Accumulated Depreciation
2,801.01
2,187.72
1,594.80
1,221.36
934.45
710.27
544.70
458.33
402.77
328.73
Non Current Assets
8,595.61
8,713.53
8,704.89
4,512.74
4,085.66
3,768.25
1,599.69
1,191.87
1,060.78
941.27
Capital Work in Progress
711.93
617.12
646.94
519.49
1,041.58
678.33
534.11
285.28
113.55
179.88
Non Current Investment
2.09
2.09
0.09
0.09
0.09
0.06
0.03
0.03
37.52
20.00
Long Term Loans & Adv.
222.19
150.58
130.96
182.32
99.66
206.92
129.47
62.84
61.37
59.51
Other Non Current Assets
126.28
196.03
72.22
122.40
85.25
50.28
60.74
23.90
46.25
46.34
Current Assets
5,008.97
5,037.54
5,262.41
4,879.47
4,689.03
4,051.41
3,404.48
2,560.89
1,987.12
1,594.42
Current Investments
0.02
351.35
492.27
803.55
779.59
297.59
185.63
60.44
86.52
125.99
Inventories
2,148.22
1,935.15
1,966.30
1,559.15
1,357.98
1,067.17
1,006.06
923.86
531.56
504.83
Sundry Debtors
1,649.34
1,435.71
1,253.45
950.89
1,445.09
1,587.26
1,099.42
687.82
522.80
340.40
Cash & Bank
666.65
816.04
867.23
893.72
647.03
567.36
769.42
626.97
674.28
478.80
Other Current Assets
544.74
405.83
587.77
589.54
459.34
532.03
343.95
261.80
171.96
144.41
Short Term Loans & Adv.
101.53
93.46
95.39
82.62
90.18
109.09
84.95
75.95
56.46
49.28
Net Current Assets
-473.24
-127.78
60.24
2,141.21
1,403.55
1,227.66
1,229.90
850.24
624.28
480.33
Total Assets
13,604.58
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
3,047.90
2,535.69

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
1,391.79
1,798.08
894.15
1,008.84
2,742.12
810.20
599.42
153.48
499.13
395.01
PBT
1,186.57
561.66
931.01
1,088.09
2,343.44
939.81
843.98
581.60
358.62
342.33
Adjustment
875.09
1,418.19
606.92
430.27
552.44
337.96
136.79
126.13
79.64
74.80
Changes in Working Capital
-385.83
99.39
-360.16
-125.21
423.58
-409.38
-119.68
-421.75
143.58
61.88
Cash after chg. in Working capital
1,675.83
2,079.24
1,177.77
1,393.15
3,319.46
868.39
861.09
285.98
581.84
479.01
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-284.04
-281.16
-283.62
-384.31
-577.34
-58.19
-261.67
-132.50
-82.71
-84.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-151.57
-241.28
-4,706.95
-786.91
-837.85
-2,162.30
-355.81
-241.70
-136.97
-232.60
Net Fixed Assets
-378.80
-610.74
-4,245.22
-592.01
-471.42
-2,266.57
-308.01
-455.28
-84.67
-52.13
Net Investments
351.33
138.83
310.79
-17.69
-484.32
-111.97
-131.60
287.55
-47.29
-199.04
Others
-124.10
230.63
-772.52
-177.21
117.89
216.24
83.80
-73.97
-5.01
18.57
Cash from Financing Activity
-1,549.04
-1,314.45
3,417.39
-192.91
-1,435.15
1,212.25
86.40
19.73
-192.74
-67.61
Net Cash Inflow / Outflow
-308.82
242.35
-395.41
29.02
469.12
-139.85
330.01
-68.49
169.42
94.80
Opening Cash & Equivalents
940.06
702.04
1,067.57
1,049.86
612.38
955.05
687.41
760.80
604.79
510.45
Closing Cash & Equivalent
661.82
940.06
702.04
1,067.57
1,049.86
864.95
955.05
687.41
760.80
604.79

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
284.99
279.15
273.11
257.04
206.46
147.16
112.41
84.02
70.54
60.42
ROA
7.49%
3.15%
5.81%
10.28%
20.89%
11.71%
15.16%
12.79%
10.26%
12.04%
ROE
21.47%
9.34%
15.12%
23.80%
57.92%
34.19%
39.94%
33.25%
25.84%
29.15%
ROCE
15.28%
9.75%
13.81%
20.36%
45.63%
26.98%
35.06%
31.66%
23.65%
25.88%
Fixed Asset Turnover
1.48
1.50
1.57
1.35
1.82
1.88
3.11
2.60
2.50
2.48
Receivable days
37.65
33.84
35.74
74.66
82.76
105.19
77.81
68.65
58.33
52.95
Inventory Days
49.84
49.09
57.16
90.90
66.19
81.17
84.02
82.53
70.03
68.69
Payable days
134.37
140.28
150.99
171.27
204.35
176.11
158.58
143.69
136.22
103.96
Cash Conversion Cycle
-46.89
-57.35
-58.09
-5.72
-55.41
10.25
3.25
7.50
-7.86
17.68
Total Debt/Equity
1.21
1.28
1.40
0.58
0.67
1.10
0.59
0.49
0.48
0.56
Interest Cover
3.63
2.11
4.02
6.29
13.74
6.37
15.40
18.21
10.09
9.75

News Update:


  • Torrent Pharmaceuticals redeems NCDs of Rs 83 crore
    26th Jun 2020, 10:10 AM

    The said Non-Convertible Debentures repaid by the Company on June 24, 2020

    Read More
  • Torrent Pharma - Quarterly Results
    26th May 2020, 12:00 AM

    Read More
  • Torrent Pharmaceuticals raises funds worth Rs 200 crore via NCDs
    15th May 2020, 09:48 AM

    The tenure of the instrument is 1072 days and will mature on April 21, 2023

    Read More
  • Torrent Pharmaceuticals raises Rs 195 crore via NCDs
    25th Apr 2020, 14:23 PM

    The date of maturity of the said instruments is April 24, 2023

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.